Symbiox Investment & Trading Fair Value
Symbiox Investment & Trading (SYMBIOX) average fair value is ₹5.64 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹1.96 (+187.86%), fair value range ₹0.31–₹15.48. For live price and a broader fundamental view, visit Symbiox Investment & Trading share price chart.
Fair Value Analysis Export
SYMBIOX Fair Value vs Current Price — Valuation Summary
SYMBIOX average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Explore SYMBIOX investment value to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
SYMBIOX Fair Value Analysis — Data Sources & Coverage
Symbiox Investment & Trading financial data sources, valuation methods applied and sector benchmarks used — 2015 financial year. Examine SYMBIOX quarterly performance for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is 11 years old (2015).
SYMBIOX vs Financial Services Sector Peers — P/E, P/B & Market Cap
Symbiox Investment & Trading P/E ratio, P/B ratio and market capitalisation vs Financial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Trishakti Electronics | TRISHAKT | 36.55 | 3.54 | ₹235 |
| Virat Leasing | VLL | - | 6.91 | ₹112 |
| Ajcon Global Services | AJCON | - | 1.68 | ₹37 |
| Nexome Capital Markets | NEXOME | 58.26 | 0.51 | ₹92 |
| Mrugesh Trading | MRUTR | - | 10.17 | ₹1,451 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.